PubMed Health⌕ Search

Biomedical subjects

M Seyfarth

Publications and source records attributed to M Seyfarth.

At least 73 records · Page 4Linked to original sources

Neurogenic control of pressure natriuresis in conscious dogs.

In this study we investigated the interaction of the sympathetic nervous system with renal perfusion pressure (RPP) in the short-term control of sodium excretion (UNa V). Pressure natriuresis curves (PNCs) were determined in 13 conscious dogs on a normal-salt diet during control conditions, bilateral common carotid occlusion (CCO), CCO combined with an intrarenal prazosin infusion, and during an intrarenal methoxamine infusion. RPP was reduced in controlled steps by inflation of a cuff placed around the renal artery. For controls, a reduction in RPP resulted in a strong decrease in urine output and UNaV. In all dogs, the PNC was closely related to individual resting blood pressure; UNaV fell to less than 50% of control (10-20 mmHg below resting blood pressure). A baroreflex activation of the sympathetic nervous system by CCO shifted PNC to the right by 10-15 mmHg (n = 8). Sensitivity of pressure natriuresis was not affected by CCO. The shift was blocked when the selective alpha 1-adrenoceptor antagonist prazosin was infused intrarenally during CCO (n = 9). Without CCO, prazosin had no effects on urine flow rate or UNaV at the control RPP. Similar to CCO, intrarenal infusion of the selective alpha 1-adrenoceptor agonist methoxamine shifted PNC to the right by 15-20 mmHg (n = 4). Neither renal blood flow nor glomerular filtration rate was significantly different between control and any experimental condition. These results indicate that the sympathetic nervous system regulates UNaV by shifting the PNC through intrarenal alpha 1-adrenoceptors without altering the sensitivity of pressure natriuresis.

Animals↗

[Determination of secretory immunoglobulin A in urine of children with enzyme immunoassay].

The estimation of secretory immunoglobulin A (sIgA) by an enzyme immunoassay (EIA) was used as heterogenic solid-phase assay. A monoclonal antibody directed against the human secretoric part and a peroxidase-marked anti-IgA serum may mediate the reaction. The test was evaluated on urine of 59 healthy children aged from 0-14 years. An age-dependent increase of sIgA concentration (mg/l) and excretion up to the 6th months of life was found. Thereafter the concentration did reach a constant value of 0.5 mg/l sIgA and 0.4 mg sIgA/g creatinine, respectively. The normal values may follow a logarithmic distribution. The presented method is highly sensitive, simple and safe.

Adolescent↗

Secretory immunoglobulin A in serum of CF patients.

Increased sIgA values were found in CF patients in about 70 per cent (3 studies with 23, 43, 45 CF patients). With higher severity of CF disease (Shwachman score) we could observe higher sIgA levels. Postmortem histological findings and sIgA concentrations correlated well in 13 cases. Determinations of sIgA in serum could serve as parameter for hepatobiliary involvement in CF. Secretory immunoglobulin A (sIgA) is the predominant immunoglobulin of exocrine secretions. In serum large and frequent elevations of sIgA could be found in patients with chronic liver disease characterized by biliary obstruction (3). Slight and irregular elevations were observed in patients with disorders of gastrointestinal tract and of respiratory tract as well as in lactating women (3). Manifestations of the hepatobiliary system in CF will become more important with advancing age and progressively higher life expectancy of CF patients. A simple reliable test for detection of hepatobiliary involvement in CF would be useful.

Biliary Tract Diseases↗

[Detection of IgA in diseased skin and serum of patients with psoriasis vulgaris].

Origin and function of IgA in the psoriatic skin are unknown. Including a monoclonal antibody against the secretory component (SC) of the secretory IgA (SIga), we have tried to characterize the IgA in psoriasis. With help of a polyclonal antiserum we found depots of IgA in the skin in 69% of all investigated patients. There was a correlation between the degree of akanthosis and the amount of intraepidermal IgA. In the serum of the psoriasis total IgA was significant increased, but never we found SC-bound SIgA in the skin or elevated levels in serum of patients.

Adult↗

Secretory immunoglobulin A (sIgA) in the serum of cystic fibrosis patients.

Clearly increased sIgA values were found in cystic fibrosis patients in more than 70%. The highest concentrations were seen in patients with obstructive liver disease. There were no correlations between sIgA and liver-associated enzymes. Postmortem histology and sIgA correlated well. These data suggest a pertinent role of sIgA assessment in evaluation of hepatic involvement in cystic fibrosis.

Adolescent↗

X-linked hypogammaglobulinaemia with a late secretion defect. A family study.

Three boy cousins suffering from x-linked hypogammaglobulinaemia have been described. Their disease is quite different from the classical x-linked hypogammaglobulinaemia. We present data from 15 family members of three families. The three mothers are sisters and 3 boys from 5 are suffering from immunodeficiency. HLA A, B and DR typing and in vitro diagnostics of immune functions of all family members were carried out. In the patients we could demonstrate a well functioning T cell system which seems to be regular for T cell help on PMW driven B cell maturation into cytoplasmic immunoglobulin positive (cIg+) cells of all immunoglobulin classes but we had no evidence for IgG secreting cells in a plaque forming cell (PFC) assay. The registration of spontaneous suppressor phenomena should be taken into account. If patients undergo an gamma-globulin therapy the changed suppressor effects come back to normal values but the secretion defect is unchanged. The three healthy mothers express one identical haplotype (A2 B8 DR3) which we could demonstrate in the three patients but also in one healthy boy.

Agammaglobulinemia↗

[Importance of secretory IgA in human body fluids. I. Development of an enzyme immunoassay for secretory IgA].

This paper describes an enzyme-immunoassay for the quantitative estimation of secretory IgA(S-IgA). As solid phase a monoclonal antibody against human secretory component was used, a polyclonal peroxidase labeled anti-IgA serum as conjugate. Thus, the method was specific for S-IgA. The test was done in microtiter plates, the upper limit was 0.5 ng S-IgA/ml. The standards of our test system ran in normal ranges, the coefficients of variation were 6.9% in the within-day-test and 12.2% in the day-to-day-test. The described test system is effective and sensitive. It is suitable for clinical use.

Antibodies, Monoclonal↗

[Determination of S-IgA and free secretory component in saliva].

Saliva of 95 patients of different ages was investigated for S-IgA and free secretory component (SC). The two-directional rocket method was used as assay for separating S-IgA and free SC in the presence of heparin-Ca-EDTA. The method employs electrophoresis in an antibody containing agarose/agar gel.--The value of S-IgA in children about 4 years old was 40,0 mg/l and the relation of free SC to S-IgA was 1 to 5. The S-IgA level in patients over 50 years old was 55,2 mg/l, in no case free SC was detectable.

Age Factors↗

[Evaluation of clinical efficacy of platelet substitution in acute leukemia using resonance thrombography].

For evaluating the clinical effectiveness of thrombocyte substitution, the resonance thrombogram was registered before and after thrombocyte substitution in 50 patients with acute leukemia and the increase of thrombocytes (corrected increment) determined. Thrombocyte substitution led to a significant diminution of the platelet amplitude (p less than 0.01) and platelet value. The highest value of these alterations of parameters was reached 1 hour after transfusion, it was somewhat lower after 24 hours, yet the initial value was not reached again. Correlations could be found to exist between the platelet amplitude and the corrected thrombocyte increase 1 hour and 24 hours after transfusion. The resonance thrombography enables the successful control of thrombocyte substitution to be made and it is suitable for monitoring hemostasis in severe thrombocytopenia due to production.

Acute Disease↗

Cellular immunity in glomerulonephritis.

58 patients (25 with GN, 13 with PN, 10 with hypernephroma, and 10 healthy controls) were tested for t-cell activity against glomerular basement membrane antigen (GBMA), total renal antigen (TRA), hypernephroma antigen (HyA), HEP, and PPD by means of the electrophoretic mobility test described by Field and Caspary. Positive reactions to GMBA were demonstrated in 21 to 25 GN patients, and 2 of 13 PN patients. There was no reaction among the hypernephroma patients or the controls. Lymphocytes from all 10 hypernephroma patients, but only 1 of the other 37 patients tested, were sensitized against HyA. No conclusion may be drawn regarding the pathogenetic relevance of the findings, but attention is drawn to the diagnostic value of tests based on these results.

Adolescent↗